Lindbrook Capital, LLC Caribou Biosciences, Inc. Transaction History
Lindbrook Capital, LLC
- $1.09 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding CRBU
# of Institutions
141Shares Held
52.8MCall Options Held
157KPut Options Held
99.7K-
Black Rock Inc. New York, NY6.95MShares$9.38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.57MShares$6.16 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.88MShares$5.23 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.75MShares$3.71 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.5MShares$3.37 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $82.1M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...